Back to Search
Start Over
The G-250A polymorphism in the hepatic lipase gene promoter is associated with changes in hepatic lipase activity and LDL cholesterol: The KANWU Study.
- Source :
-
Nutrition, metabolism, and cardiovascular diseases : NMCD [Nutr Metab Cardiovasc Dis] 2008 Feb; Vol. 18 (2), pp. 88-95. Date of Electronic Publication: 2007 Feb 26. - Publication Year :
- 2008
-
Abstract
- Background and Aims: Hepatic lipase (HL) catalyzes the hydrolysis of triglycerides and phospholipids from lipoproteins, and promotes the hepatic uptake of lipoproteins. A common G-250A polymorphism in the promoter of the hepatic lipase gene (LIPC) has been described. The aim was to study the effects of the G-250A polymorphism on HL activity, serum lipid profile and insulin sensitivity.<br />Methods and Results: Altogether 151 healthy subjects (age 49+/-8 years, BMI 26.5+/-3.0kg/m(2)) were randomly assigned for 3 months to an isoenergetic diet containing either a high proportion of saturated fatty acids (SFA diet) or monounsaturated fatty acids (MUFA diet). Within groups there was a second random assignment to supplements with fish oil (3.6g n-3 FA/day) or placebo. At baseline, the A-250A genotype was associated with high serum LDL cholesterol concentration (P=0.030 among three genotypes). On the MUFA diet carriers of the A-250A genotype presented a greater decrease in LDL cholesterol concentration than subjects with other genotypes (P=0.007 among three genotypes). The rare -250A allele was related to low HL activity (P<0.001 among three genotypes). The diet did not affect the levels of HL activity among the genotypes.<br />Conclusion: The A-250A genotype of the LIPC gene was associated with high LDL cholesterol concentration, but the MUFA-enriched diet reduced serum LDL cholesterol concentration especially in subjects with the A-250A genotype.
- Subjects :
- Adult
Australia
Blood Glucose drug effects
Europe
Fatty Acids administration & dosage
Fatty Acids, Monounsaturated administration & dosage
Female
Fish Oils administration & dosage
Gene Expression Regulation, Enzymologic drug effects
Gene Frequency
Genetic Predisposition to Disease
Humans
Hypercholesterolemia genetics
Hypercholesterolemia metabolism
Insulin blood
Lipase genetics
Liver enzymology
Male
Middle Aged
Phenotype
Postprandial Period
Time Factors
Cholesterol, LDL blood
Dietary Fats administration & dosage
Hypercholesterolemia prevention & control
Insulin Resistance genetics
Lipase metabolism
Liver drug effects
Polymorphism, Single Nucleotide
Promoter Regions, Genetic
Subjects
Details
- Language :
- English
- ISSN :
- 1590-3729
- Volume :
- 18
- Issue :
- 2
- Database :
- MEDLINE
- Journal :
- Nutrition, metabolism, and cardiovascular diseases : NMCD
- Publication Type :
- Academic Journal
- Accession number :
- 17327141
- Full Text :
- https://doi.org/10.1016/j.numecd.2006.09.008